Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Return on Sales (2016 - 2025)

Historic Return on Sales for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to 198.68%.

  • Kyntra Bio's Return on Sales fell 550400.0% to 198.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.79%, marking a year-over-year decrease of 179900.0%. This contributed to the annual value of 14.66% for FY2024, which is 138300.0% up from last year.
  • As of Q3 2025, Kyntra Bio's Return on Sales stood at 198.68%, which was down 550400.0% from 4.51% recorded in Q2 2025.
  • Kyntra Bio's 5-year Return on Sales high stood at 253.72% for Q3 2024, and its period low was 45.59% during Q1 2023.
  • Over the past 5 years, Kyntra Bio's median Return on Sales value was 1.6% (recorded in 2023), while the average stood at 23.88%.
  • As far as peak fluctuations go, Kyntra Bio's Return on Sales soared by 2553300bps in 2024, and later plummeted by -743700bps in 2025.
  • Over the past 5 years, Kyntra Bio's Return on Sales (Quarter) stood at 8.13% in 2021, then soared by 76bps to 1.93% in 2022, then soared by 165bps to 1.26% in 2023, then crashed by -210bps to 1.38% in 2024, then skyrocketed by 14480bps to 198.68% in 2025.
  • Its Return on Sales stands at 198.68% for Q3 2025, versus 4.51% for Q2 2025 and 11.89% for Q1 2025.